HIT Consultant January 26, 2024
Jasmine Pennic

What You Should Know:

Deliberate AI, a digital health company harnessing AI to revolutionize mental health assessment, has secured a major milestone in its mission. The U.S. Food and Drug Administration (FDA) has selected Deliberate AI’s AI-generated Clinical Outcome Assessment (AI-COA™) for its Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program.

– The collaboration between Deliberate AI and the FDA represents a giant leap in the fight against mental illness. By harnessing the power of AI, we can accelerate drug development, improve treatment efficacy, and ultimately empower patients to live healthier, happier lives

AI-COA™: A Beacon of Precision in Mental Health

Deliberate AI’s AI-COA™ leverages cutting-edge multimodal signal processing and machine learning to capture mental health...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Digital Health, FDA, Govt Agencies, Mental Health, Provider, Technology
AI Popular Myth Of Achieving Perfect AGI Versus Harsh Reality We Truly Face
AI Agents Are Like Love: Wanted Everywhere, Understood Nowhere
Apple Is Caught In Its Own Dangerous Catch-22
Launching your first AI project with a grain of RICE: Weighing reach, impact, confidence and effort to create your roadmap
Is Generative AI Pushing People Toward Addictions?

Share This Article